跳至主要内容
临床试验/NCT05836168
NCT05836168进行中(未招募)不适用

Effects of Microbiome Modulation on Sleep in Working People: A Randomized Controlled Pilot Trial

Medical University of Graz1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2023年5月31日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
100
试验地点
1
主要终点
Change in subjective sleep quality

研究概览

简要总结

We aim to test whether quality of sleep in working people can be improved by modulating the gut microbiome with probiotics.

详细描述

A good night´s sleep is essential for our attention, cognition and mood. Sleep fragmentation can therefore lead to poor performance, loss of productivity, and errors, incidents and accidents in the workplace. Sleep disruption has further been associated with metabolic and cardiovascular diseases, psychiatric diseases and cancer.The gut microbiome and its metabolites exhibit diurnal rhythmicity in response to food intake and influence human clock gene expression and sleep duration. Sleep fragmentation causes dysbiosis and hormonal disturbances. First data from animal experiments and small human studies imply that modulation of the gut microbiome may improve sleep quality and thereby mental and physical health. Probiotics can alter the gut microbiota composition and can mitigate positive effects on psychiatric symptoms via the microbiome gut-brain axis by metabolites such as short-chain fatty acids (SCFA) that can pass the blood-brain barrier and thereby comprise a potential strategy to improve sleep quality and other quality of life related outcomes. Evidence on the effect of probiotics to improve quality of sleep is available from several small-scale clinical studies in different populations. The benefit seems to be stronger in people under physical or mental stress.

Also, a large marketing survey conducted in Germany in over >10.000 consumers indicated that a multispecies probiotic, that has been described to improve inflammation, gut barrier dysfunction and immune function in different patient cohorts is able to improve sleep quality and quality of life, however since this study was non-randomized, a bias cannot be excluded.

Understanding the interaction between the gut microbiome, chronobiology and health is therefore of high importance and in line with the United Nations' Sustainable Development Goal 3 of the 2030 Agenda for Sustainable Development to "ensure healthy lives and promoting well-being for all at all ages".

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

placebo, outcome assessors are blinded to the group allocation

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed Informed Consent;
  • Willing to accept use of all encoded data, including publication, and the confidential use and storage of all data for at least 15 years
  • Pittsburgh Sleep Quality index score of >5

排除标准

  • Diagnosed with a gastrointestinal infection within 4 weeks prior to screening
  • Severe gastrointestinal diseases (e.g. inflammatory bowel diseases)
  • Received any of the following products/medication within 4 weeks prior to screening: systemic antibiotics, prokinetics, prebiotic supplements, probiotic supplements
  • Concomitant diseases or other circumstances that suggest that the patients are not eligible for participation in the study

结局指标

主要结局

Change in subjective sleep quality

时间窗: 4 weeks

Pittsburgh Sleep Quality Index (PSQI)

次要结局

  • sleep duration(4 weeks)
  • habitual sleep efficiency(4 weeks)
  • sleep latency(4 weeks)
  • sleep disturbances(4 weeks)
  • use of sleeping medication(4 weeks)
  • daytime dysfunction(4 weeks)
  • Gastrointestinal quality of life(4 weeks)
  • Quality of life(4 weeks)
  • perceived stress levels(4 weeks)

研究者

发起方
Medical University of Graz
申办方类型
Other
责任方
Principal Investigator
主要研究者

Vanessa Stadlbauer-Koellner, MD

Univ. Prof. PD Dr. med

Medical University of Graz

研究点 (1)

Loading locations...

相似试验